Prenatal diagnosis and prevalence of critical congenital heart defects: an international retrospective cohort study.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
02 07 2019
Historique:
entrez: 5 7 2019
pubmed: 5 7 2019
medline: 3 7 2020
Statut: epublish

Résumé

To assess international trends and patterns of prenatal diagnosis of critical congenital heart defects (CCHDs) and their relation to total and live birth CCHD prevalence and mortality. Fifteen birth defect surveillance programmes that participate in the International Clearinghouse for Birth Defects Surveillance and Research from 12 countries in Europe, North and South America and Asia. Live births, stillbirths and elective terminations of pregnancy for fetal anomaly diagnosed with 1 of 12 selected CCHD, ascertained by the 15 programmes for delivery years 2000 to 2014. 18 243 CCHD cases were reported among 8 847 081 births. The median total prevalence was 19.1 per 10 000 births but varied threefold between programmes from 10.1 to 31.0 per 10 000. CCHD were prenatally detected for at least 50% of the cases in one-third of the programmes. However, prenatal detection varied from 13% in Slovak Republic to 87% in some areas in France. Prenatal detection was consistently high for hypoplastic left heart syndrome (64% overall) and was lowest for total anomalous pulmonary venous return (28% overall). Surveillance programmes in countries that do not legally permit terminations of pregnancy tended to have higher live birth prevalence of CCHD. Most programmes showed an increasing trend in prenatally diagnosed CCHD cases. Prenatal detection already accounts for 50% or more of CCHD detected in many programmes and is increasing. Local policies and access likely account for the wide variability of reported occurrence and prenatal diagnosis. Detection rates are high especially for CCHD that are more easily diagnosed on a standard obstetric four-chamber ultrasound or for fetuses that have extracardiac anomalies. These ongoing trends in prenatal diagnosis, potentially in combination with newborn pulse oximetry, are likely to modify the epidemiology and clinical outcomes of CCHD in the near future.

Identifiants

pubmed: 31270117
pii: bmjopen-2018-028139
doi: 10.1136/bmjopen-2018-028139
pmc: PMC6609145
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e028139

Informations de copyright

© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Circulation. 2001 May 15;103(19):2376-81
pubmed: 11352887
Eur Heart J. 2016 Feb 14;37(7):621-6
pubmed: 26341891
Am J Clin Nutr. 2010 Jun;91(6):1543-9
pubmed: 20375192
Eur J Obstet Gynecol Reprod Biol. 2016 Aug;203:260-3
pubmed: 27359082
Circulation. 2007 Jun 12;115(23):2995-3014
pubmed: 17519397
BJOG. 2008 Aug;115(9):1096-100
pubmed: 18518870
Ultrasound Obstet Gynecol. 2003 Jan;21(1):19-25
pubmed: 12528156
Circulation. 2014 Jan 21;129(3):285-92
pubmed: 24135071
Ultrasound Obstet Gynecol. 2015 Jun;45(6):631-8
pubmed: 25904437
Prenat Diagn. 2015 Sep;35(9):859-63
pubmed: 25989740
Congenit Heart Dis. 2017 Jan;12(1):67-73
pubmed: 27561699
Pediatr Cardiol. 2014 Oct;35(7):1232-8
pubmed: 24823884
MMWR Morb Mortal Wkly Rep. 2017 Jan 20;66(2):41-46
pubmed: 28103210
Ultrasound Obstet Gynecol. 2006 Jan;27(1):107-13
pubmed: 16374757
Can J Cardiol. 2017 Jun;33(6):792-798
pubmed: 28457736
J Pediatr. 2008 Dec;153(6):807-13
pubmed: 18657826
Ultrasound Obstet Gynecol. 2014 Jul;44(1):58-63
pubmed: 24443357
Am J Epidemiol. 2017 Jul 1;186(1):118-128
pubmed: 28505225
Am J Obstet Gynecol. 2010 Jan;202(1):51.e1-51.e10
pubmed: 19796755
Arch Dis Child. 2012 Oct;97(10):861-5
pubmed: 22753769
Ultrasound Obstet Gynecol. 2012 Oct;40(4):418-25
pubmed: 21998002
BJOG. 2016 Feb;123(3):400-7
pubmed: 25625301
Pediatrics. 2013 May;131(5):e1502-8
pubmed: 23610203
J Ultrasound Med. 2009 Jul;28(7):889-99
pubmed: 19546331
Circulation. 1999 Feb 23;99(7):916-8
pubmed: 10027815
Cardiol Young. 2018 Apr;28(4):548-553
pubmed: 29409551
Heart. 2012 Mar;98(6):474-9
pubmed: 22294555
Circulation. 2011 Mar 1;123(8):841-9
pubmed: 21321151
Int J Gynaecol Obstet. 2018 Feb;140(2):137-145
pubmed: 29094357
J Paediatr Child Health. 2006 Nov;42(11):704-8
pubmed: 17044898
BMC Pregnancy Childbirth. 2015 Aug 15;15:171
pubmed: 26276642
Prenat Diagn. 2014 Dec;34(13):1235-45
pubmed: 25052917
JAMA Cardiol. 2018 Sep 1;3(9):829-837
pubmed: 30027209
Circulation. 2001 Mar 6;103(9):1269-73
pubmed: 11238272
Circulation. 2010 Nov 30;122(22):2254-63
pubmed: 21098447
Ultrasound Obstet Gynecol. 2006 Nov;28(6):779-84
pubmed: 17031872
Arch Dis Child Fetal Neonatal Ed. 2018 Jan;103(1):F22-F28
pubmed: 28667189
Pediatrics. 2015 Aug;136(2):e378-85
pubmed: 26216324

Auteurs

Marian K Bakker (MK)

Department of Genetics, Eurocat registration Northern Netherlands, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

Jorieke E H Bergman (JEH)

Department of Genetics, Eurocat registration Northern Netherlands, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

Sergey Krikov (S)

Division of Medical Genetics, Department of Pediatrics, University of Utah, Salt Lake City, Utah, USA.

Emmanuelle Amar (E)

Registre Des Malformations en Rhone Alpes, REMERA, Lyon, France.

Guido Cocchi (G)

Neonatology Unit, S.Orsola-Malpighi Hospital, Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.

Janet Cragan (J)

Metropolitan Atlanta Congenital Defects Program, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Hermien E K de Walle (HEK)

Department of Genetics, Eurocat registration Northern Netherlands, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

Miriam Gatt (M)

Malta Congenital Anomalies Registry, Directorate for Health Information and Research, Malta, Malta.

Boris Groisman (B)

National Network of Congenital Anomalies of Argentina (RENAC), National Center of Medical Genetics, National Ministry of Health, Buenos Aires, Argentina.

Shiliang Liu (S)

Maternal, Child and Youth Health Division, Public Health Agency of Canada, Ottawa, Canada.

Wendy N Nembhard (WN)

Arkansas Reproductive Health Monitoring System, University of Arkansas for Medical Sciences, Fay W Boozman College of Public Health and the Arkansas Children's Research Institute, Little Rock, Arkansas, USA.

Anna Pierini (A)

Institute of Clinical Physiology, National Research Council and Fondazione Toscana Gabriele Monasterio, Tuscany Registry of Congenital Defects, Pisa, Italy.

Anke Rissmann (A)

Malformation Monitoring Centre, Medical Faculty, Otto von Guericke University, Magdeburg, Germany.

Shanthi Chidambarathanu (S)

Birth Defects Registry of India, Mediscan Systems, Chennai, India.

Antonin Sipek (A)

Institute of Medical Biology and Genetics First Faculty of Medicine Charles University and General University Hospital, Prague, Czech Republic.

Elena Szabova (E)

Slovak Teratologic Information Centre (FPH), Slovak Medical University, Bratislava, Slovakia.

Giovanna Tagliabue (G)

Lombardy Birth Defects Registry, Fondazione IRCCS Instituto Nazionale Tumori, Milan, Italy.

David Tucker (D)

Congenital Anomaly Register and Information Service for Wales, Public Health Wales, Swansea, Wales, UK.

Pierpaolo Mastroiacovo (P)

International Center on Birth Defects, University of Utah, Salt Lake City, Utah, USA.

Lorenzo D Botto (LD)

Division of Medical Genetics, Department of Pediatrics, University of Utah, Salt Lake City, Utah, USA.
International Center on Birth Defects, University of Utah, Salt Lake City, Utah, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH